Clinical Trials Related to PTC Therapeutics

Related studies linked through entity extraction aliases.

Study of Ataluren (PTC124) in Hemophilia A and B

Status: TERMINATED
Phase: PHASE2

PTC299 for Treatment of Neurofibromatosis Type 2

Status: TERMINATED
Phase: PHASE2

Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

Status: TERMINATED
Phase: PHASE2

Study of Ataluren (PTC124™) in Cystic Fibrosis

Status: COMPLETED
Phase: PHASE3

Phase 2a Extension Study of Ataluren (PTC124) in Duchenne Muscular Dystrophy (DMD)

Status: TERMINATED
Phase: PHASE2

PTC299 for Treatment of Advanced Cancer

Status: TERMINATED
Phase: PHASE1

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

Status: TERMINATED
Phase: PHASE1/PHASE2

Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

Status: COMPLETED
Phase: PHASE2

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

Status: COMPLETED
Phase: PHASE1

A Study of Ataluren in Pediatric Participants With Cystic Fibrosis

Status: COMPLETED
Phase: PHASE2

PTC124 for the Treatment of Cystic Fibrosis

Status: COMPLETED
Phase: PHASE2

Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy

Status: COMPLETED
Phase: PHASE2

Safety and Efficacy of Ataluren (PTC124) for Cystic Fibrosis

Status: COMPLETED
Phase: PHASE2

PTC124 for Cystic Fibrosis

Status: COMPLETED
Phase: PHASE2